Trexquant Investment LP grew its position in IMAX Co. (NYSE:IMAX – Free Report) by 12.1% in the 4th quarter, Holdings Channel reports. The institutional investor owned 220,452 shares of the company’s stock after purchasing an additional 23,876 shares during the period. Trexquant Investment LP’s holdings in IMAX were worth $5,644,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in IMAX. Intech Investment Management LLC acquired a new stake in IMAX in the third quarter worth about $205,000. FMR LLC boosted its stake in shares of IMAX by 108.4% in the 3rd quarter. FMR LLC now owns 3,949,643 shares of the company’s stock valued at $81,007,000 after purchasing an additional 2,054,031 shares during the last quarter. Quarry LP grew its position in shares of IMAX by 78,333.3% during the 3rd quarter. Quarry LP now owns 2,353 shares of the company’s stock worth $48,000 after buying an additional 2,350 shares during the period. Systematic Financial Management LP bought a new stake in shares of IMAX during the third quarter worth approximately $838,000. Finally, Castleark Management LLC acquired a new position in IMAX in the third quarter valued at approximately $5,199,000. Institutional investors own 93.51% of the company’s stock.
IMAX Stock Performance
Shares of IMAX stock opened at $24.38 on Friday. IMAX Co. has a 52 week low of $14.94 and a 52 week high of $27.77. The company’s 50 day moving average price is $25.48 and its two-hundred day moving average price is $24.01. The company has a market capitalization of $1.29 billion, a P/E ratio of 49.76, a price-to-earnings-growth ratio of 1.49 and a beta of 0.91.
Wall Street Analyst Weigh In
A number of research firms have commented on IMAX. Rosenblatt Securities lifted their target price on shares of IMAX from $28.00 to $35.00 and gave the stock a “buy” rating in a report on Thursday, February 20th. Benchmark reiterated a “buy” rating and issued a $30.00 price objective on shares of IMAX in a report on Thursday, February 20th. JPMorgan Chase & Co. raised their target price on IMAX from $25.00 to $27.00 and gave the stock a “neutral” rating in a report on Friday, February 21st. Macquarie upped their price target on IMAX from $28.00 to $30.00 and gave the company an “outperform” rating in a research note on Thursday, February 20th. Finally, Wedbush reissued an “outperform” rating and set a $32.00 price objective on shares of IMAX in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $30.67.
Read Our Latest Stock Analysis on IMAX
About IMAX
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
See Also
- Five stocks we like better than IMAX
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What is the S&P 500 and How It is Distinct from Other Indexes
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding IMAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMAX Co. (NYSE:IMAX – Free Report).
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.